The SCD1 inhibitor aramchol interacts with regorafenib and metformin to kill tumor cells...Impact Journals LLC
The research group at the Department of Clinical and Molecular Genetics, Hiroshima University Hospital...Hiroshima University
Overview of a framework for prioritizing variants of uncertain significance (VUS) identified by comprehensive genomic pr...Hiroshima University
BRCA2:c.67G>C is associated with aberrant splicing and an exceptional response to platinum-based chemotherapy...Hiroshima University
Elisabetta Mereu's team, at the Josep Carreras Leukaemia Research Institute...Josep Carreras Leukaemia Research Institute
Nuclear medicine physician James Nagarajah from Radboudumc in the clinics...Radboud University Medical Center
